Shareholders' Equity Narrative (Details) $ / shares in Units, $ in Millions	3 Months Ended			6 Months Ended	9 Months Ended
	Sep. 30, 2023 $ / shares shares	Sep. 30, 2022 shares	Mar. 31, 2021 USD ($) $ / shares shares	Nov. 02, 2023 shares	Sep. 30, 2023 $ / shares shares	Sep. 30, 2022 shares	May 11, 2023 shares	Dec. 31, 2022 $ / shares shares
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized (in share)	10,000,000				10,000,000			10,000,000
Preferred stock, no par value (in dollars per share) | $ / shares	$ 0				$ 0			$ 0
Preferred stock, shares issued (in shares)	0				0			0
Preferred stock, shares outstanding (in shares)	0				0			0
Derivative, notional amount | $			$ 84.1
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	200,000	400,000			300,000	700,000
Deferred tax assets, derivative instruments | $			$ 20.6
Treasury stock, shares, acquired			3,700,000
Class of warrant or right, exercise price of warrants or rights | $ / shares			$ 180.00
Class of Warrant or Right, Premium, Percentage			1
Class of Warrant or Right, Aggregate Proceeds From Transaction | $			$ 45.3
2023 Stock Repruchase Program
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares authorized to be repurchased							100,000,000
2023 Stock Repruchase Program | Subsequent Event
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock repurchased during period (in shares)				0
Convertible Debt Securities [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	3,700,000		3,700,000		3,700,000
Common stock, conversion price (in dollars per share) | $ / shares	$ 126.00		$ 126.00